Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1371/journal.pone.0246536 http://scihub22266oqcxt.onion/10.1371/journal.pone.0246536 33556086!7870088!33556086     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       PLoS+One 2021 ; 16 (2): e0246536 Nephropedia Template TP {{tp|p=33556086|t=2021. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests |pdf=|usr=}}{{33556086}} gab.com Text Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests JO: PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=33556086 #FOAvip We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou Laihe Biotech, Artron Laboratories, Chil, and Nadal. In the first week after onset, Elecsys had 40% positivity in Group S (severe cases) but was negative in Group M (mild-moderate cases). The immunochromatography kits showed 40-60% and 0-8% positivity in Groups S and M, respectively. In the second week, Elecsys showed 75% and 50% positivity, and the immunochromatography tests showed 5-80% and 50-75% positivity in Groups S and M, respectively. After the third week, Elecsys showed 100% positivity in both groups. The immunochromatography kits showed 100% positivity in Group S. In Group M, positivity decreased to 50% for Chil and 75-89% for Artron and Lyher. Elecsys and immunochromatography kits had 91-100% specificity. Elecsys had comparable chronological change of cut-off index values in the two groups from the second week to the sixth week. The current SARS-CoV-2 antibody detection tests do not provide meaningful interpretation of severity and infection status. Its use might be limited to short-term epidemiological studies. Twit Text FOAVip Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests ????PLoS One http://www.kidney.de/pget.php?&tw=1&pmid=33556086 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33556086 #FOAvip English Wikipedia <ref>{{Cite pmid|33556086}}</ref> Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests #MMPMID33556086 Wakita M; Idei M; Saito K; Horiuchi Y; Yamatani K; Ishikawa S; Yamamoto T; Igawa G; Hinata M; Kadota K; Kurosawa T; Takahashi S; Saito T; Misawa S; Akazawa C; Naito T; Miida T; Takahashi K; Ai T; Tabe Y PLoS One 2021[]; 16 (2): e0246536 PMID33556086show ga We examined the usefulness of five COVID-19 antibody detection tests using 114 serum samples at various time points from 34 Japanese COVID-19 patients. We examined Elecsys Anti-SARS-CoV-2 from Roche, and four immunochromatography tests from Hangzhou Laihe Biotech, Artron Laboratories, Chil, and Nadal. In the first week after onset, Elecsys had 40% positivity in Group S (severe cases) but was negative in Group M (mild-moderate cases). The immunochromatography kits showed 40-60% and 0-8% positivity in Groups S and M, respectively. In the second week, Elecsys showed 75% and 50% positivity, and the immunochromatography tests showed 5-80% and 50-75% positivity in Groups S and M, respectively. After the third week, Elecsys showed 100% positivity in both groups. The immunochromatography kits showed 100% positivity in Group S. In Group M, positivity decreased to 50% for Chil and 75-89% for Artron and Lyher. Elecsys and immunochromatography kits had 91-100% specificity. Elecsys had comparable chronological change of cut-off index values in the two groups from the second week to the sixth week. The current SARS-CoV-2 antibody detection tests do not provide meaningful interpretation of severity and infection status. Its use might be limited to short-term epidemiological studies. |Adult[MESH] |Aged[MESH] |Antibodies, Viral/*immunology[MESH] |COVID-19 Serological Testing/*methods[MESH] |COVID-19/*diagnosis/*immunology/virology[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Reagent Kits, Diagnostic[MESH] |SARS-CoV-2/physiology[MESH]Comparison of the clinical performance and usefulness of five SARS-CoV(epmc).pdf DeepDyve Pubget Overpricing